Spin Out R&D Oncology Company

Preclinical Oncology Services Ltd (PRECOS) has been official launched, following its spin-out from the University of Nottingham. Originally set-up as a specialist business unit of the University in 2004, the company has evolved from the research expertise of the Division of Pre-clinical Oncology (formerly Academic Unit of Cancer Studies). This unit has had successful collaborations with pharmaceutical

and biotech companies in Europe, US and Japan for over a decade..

Headed by Professor Sue Watson, who will act as Chief Scientific Officer and Dr Rajendra Kumari, Chief Operations Officer, PRECOS will continue to advance its world leading work in the evaluation of potential therapeutic agents, regimens and basic research into tumour initiation and development.

Professor Watson comments: "The spin-out of the new company is an exciting time for us. Our extensive experience as a specialised research and development service has made PRECOS a trusted and preferred partner for some of the world’s leading oncology research companies. PRECOS occupies a niche in global pre-clinical R&D and is ideally positioned to exploit the growing cancer therapy market and we are looking forward to translating our laboratory expertise in cancer drug development into medicines with real patient benefits."